From earlier studies it was known that Ectoin has the potential to prevent the induction of lung inflammation. In the recent issue of the European Respiratory Journal (Feb 2013; 41:433-442) the scientists describe that application of ectoine has also the ability to ameliorate ongoing lung inflammation. doi:10.1183/09031936.00132211
Chronic obstructive pulmonary disease (COPD) is one of the most frequent diseases in modern society. According to the World Health Organization (WHO), in 2007, 210 million people worldwide suffered from COPD. The main cause for COPD is the inhalation of air pollutants like tobacco smoke or particulate matter mainly coming from combustion processes. Effective anti-inflammatory therapies like the inhalation of glucocorticoids (cortisone) do not significantly improve the health status of the patients. The inflammatory reaction of the lung caused by the inhalation of pollutants is mostly dominated by a cell type (neutrophilic granulocytes) which is insensitive to this group of drugs.
Together with the company bitop AG, researchers at the Leibniz Research Institute of Environmental Medicine in Düsseldorf, Germany, investigated the effects of the extremolyte ectoine in a series of preclinical studies. Ectoin is a natural compound produced by bacteria which are able to survive under extreme conditions. The substance is known to stabilize cells and protect them against environmental stress.
“Exposure of the lungs to air pollution still poses a problem for the inhabitants of industrialised countries, leading to diseases like COPD with a high economic burden, and it is expected that this disease will be ranked as number three of death causing diseases within the next years. The local application of cell-protecting molecules like Ectoin is a possible new option in the treatment of COPD“ states Dr. Klaus Unfried at the IUF.
Researchers in the group of Dr. Unfried were able to demonstrate the cell-protecting capacity of Ectoin in a system of environmentally induced lung inflammation. From earlier studies it was known that Ectoin has the potential to prevent the induction of lung inflammation. In the recent issue of the well recognized European Respiratory Journal (Feb 2013; 41:433-442) the scientists describe that application of ectoine has also the ability to ameliorate ongoing lung inflammation. Together with members of the department of Traumatology and Hand Surgery and the department of Angiology, Pneumology and Cardiology of the University Clinics Düsseldorf, they were able to show that after exposure to pollutants the life span of the inflammatory cells is prolonged and thereby the inflammation is likely to be increased. The application of Ectoin in the lung prevents this enhancement of the inflammation. The biophysical stabilization of the cells reverts natural cell death to a level as it would occur without the effect of pollutants and, therefore, leads to a reduction of the inflammation. The relevance of this mechanism for humans was demonstrated using inflammatory cells isolated from the blood of COPD patients.
“Different studies with ectoine-containing products have shown good results in efficacy and safety in the treatment of allergic rhinitis or atopic dermatitis. An Ectoin containing inhalation solution has already shown first positive proof of concept results after application with patients suffering from mild asthma or pollutant induced lung inflammation. Based on the actual results from the IUF we are optimistic to further explore potential applications in humans " says Dr. Andreas Bilstein, Director at bitop AG.
Dr. Katharina Beyen | idw
Further reports about: > COPD > Ectoin > Environmental Medicine > IUF > Lung inflammation > Respiratory > air pollutant > anti-inflammatory therapies > chronic obstructive pulmonary disease > cortisone > environmental risk > inflammatory cells > inhalation of glucocorticoids > neutrophilic granulocytes
Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University
Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
24.02.2017 | Life Sciences
24.02.2017 | Life Sciences
24.02.2017 | Trade Fair News